TTN and cancer: On further characterization of the immune microenvironment of TTN-mutant and wild-type cancers (Figure 2(b)), TTN-mutant tumors showed higher levels of CD8+ T cell infiltration and immune checkpoint expression, which inferred the immune microenvironment differences of TTN mutants and TTN wild types (Figures 2(c) and 2(d)).